Your Cart ( 1 Item )

• A Single-Center, Open-Label, Prospective Pilot Study of Subcutaneous Efalizumab for Oral Erosive Lichen Planus
  March 2007 | Volume 6 | Issue 3 | Original Article | 310 | Copyright © March 2007
  Michael P. Heffernan MD, David I. Smith MD, Danette Bentley MD, Mary Tabacchi, Julia E. Graves MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs